Can B Corp. Executes Definitive Agreement to Acquire the Assets of Imbibe Health Solutions
Can B Corp. Executes Definitive Agreement to Acquire the Assets of Imbibe Health Solutions
Business Entrepreneur and Advertising and Marketing Expert Walter Hoelzel to Join Can B
HICKSVILLE, NY / ACCESSWIRE / February 23, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce it has signed a definitive agreement to acquire the assets of Imbibe Health Solutions LLC ("Imbibe"), a developer and marketer of CBD and related products.
Imbibe has developed several CBD health and wellness products including topical salves, bath soaks, massage oils, and energy and dietary supplements. CANB will be putting Imbibe into one of its current inactive wholly-owned subsidiaries and will be renaming that subsidiary to reflect the products and culture that comes with the Imbibe acquisition.
Marco Alfonsi, Can B's Chief Executive Officer, commented, "We are thrilled to be bringing Walter and his Imbibe product development and marketing expertise under our Can B umbrella. In addition to adding the Imbibe Rx product line, we strongly believe Walter's advertising and marketing insights will be a great asset for us to utilize across our entire Can B segments and product lines."
Walter Hoelzel, stated, "I am proud to have brought Imbibe from initial start-up to complete product development, and believe aligning with Can B at this time is an ideal move. I am extremely impressed with the executive leadership team and the operating platform they have developed. From sourcing to manufacturing to sales channel distribution, Can B is set up for growth and a bright future."
Imbibe's CBD health and wellness products include:
Muscle & Joint Hemp Salve - a muscle and joint salve made with pure hemp extract (99% CBD) that has indicated with everyday use may help loosen muscles and joints from exercise soreness.
Unscented Fizzy Bath Soak - for a soothing and relaxing spa-like experience, six teaspoons of Fizzy Bath Soak delivers 40mgs of CBD for a soothing and relaxing spa-like experience which may help reduce inflammation and swelling.
Muscle, Joints & Back CBD Cryo Gel - fast-acting, all-natural, CBD infused, CryoGel is an all-natural blend that infuses 99% pure CBD/Hemp extract with Menthol, Camphor, and other natural ingredients.
CALM Massage Oil - with essential oils and CBD infused to enhance a calm and relaxing experience, Calm Massage Oil combines 3 essential oils - Bergamon Mint, Geranium, and Jasmine with 99% pure CBD extract for an enhanced massage experience.
Me x 3 Metabolic Energy - a new generation of metabolic energy and dietary supplement with a patented, synergetic base formulation that includes a blend of 3, all-natural ingredients.
Walter Hoelzel is a business entrepreneur and advertising and marketing expert with a 35-year career working extensively in the fields of advertising/branding, marketing, product development, and package design. Mr. Hoelzel has developed numerous highly successful private label design programs for companies like J.C. Penney's, Bloomingdales, Old Navy, and American Eagle Outfitters. He's also developed and assisted with the launch of packaging and point of sale concepts for private label manufactures working with national retailers like Walmart, Kroger, and Target to name just a few.
Mr. Hoelzel has served as creative, artistic director, and chief designer for his own brand development, advertising, publishing, and marketing firm as well as a consultant to numerous manufacturers. For the past seven years, he's been involved with the re-introduction of the Roy Rogers brand and the development of a new Broadway musical based on the life and times of Roy Rogers and Dale Evans. Most recently he has been working on new product-celebrity brand opportunities with Madison Technologies and the Casa Zeta-Jones brand.
About Can B Corp.
Can B Corp. (OTCQB:CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. CanB is also an exclusive partner of the LifeGuard® Brand in developing a line of consumer products. The Company is also launching Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA, and Green Grow Farms, a licensed hemp grow and cultivation in New York. To learn more about Can B Corp. and our comprehensive line of high-quality CBD products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
The statements contained herein have not been evaluated by the FDA. The above products are not intended to diagnose, treat, cure, or prevent any disease.
Can B Corp. (STOCK:CANB) is a U.S. based CB.D company. As product demand increases, the opportunity in Can B Corp. could be a VERY profitable one.
Even with a good deal of market volatility, CB.D stocks continue to thrive with consumers becoming far more dependent for stress and anxiety(2)
The CB.D market could be worth $89 billion by 2026
Companies like Can B Corp. (STOCK:CANB) could be in a prime position to profit from this modern day green rush
Broad support, and further state legalization of green makes this opportunity far more attractive to investors(3)
The company is also well diversified with super foods, medical devices, and supplements
The investment potential with CB.D is stunning.
By the end of the decade, the market is expected to grow 25-fold to nearly $50 billion.(4)
However, that may be a low-ball estimate with Global Market Insights noting:
“The Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026, with the global market valuation for CB.D crossing $89 billion by 2026.”(5)
As of now, demand for CB.D is surging on the heels of the pandemic.
In fact, over the last year, total sales of such consumer CB.D products just in the U.S. came in at approximately $1.2 billion, according to Nielsen Global Connect.(6)
But that’s just the start.
With a potential “second wave” of the virus, CB.D and related stocks, like Can B Corp. (STOCK:CANB) could be on the verge of breaking to higher highs.
Does CB.D Still Have More Room to Run?
Absolutely. In fact, some of the top minds in finance see further upside potential.
Again, with consumers becoming far more dependent on CBD with increased stress and anxiety with the pandemic, analysts at Nielsen say sales could reach $1.7 billion to $2 billion this year.
In addition, according to H.emp Industry Daily:
“Considering that the market could see favorable U.S. Food and Drug Administration guidance or legislation from Congress approving CBD in ingestible products next year, Nielsen expects that by 2025, the market for hemp-derived CBD products will generate $6.9 billion, – a threefold increase over five years.”(7)
But that may be a low estimate.
Analysts at Cowen say sales could reach $16 billion by 2025 with health and wellness products leading the way – and with beverage, food, and beauty playing a big role.(8)
And remember, Global Market Insights has said:
“The Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026, with the global market valuation for CB.D crossing $89 billion by 2026.”(9)
Coupled with rapidly changing consumer attitudes toward C.BD, and sizable demand from consumers, retailers can’t even stock shelves fast enough, including Neiman Marcus, Sephora, Vitamin Shoppe, Kroger, Barney’s DSW, Sephora, CVS, American Eagle, and Walgreen’s.
What Will the Election Mean for CB.D?
For one, it doesn’t matter who wins the election.
Support for CB.D is only increasing across the world. In fact, just in the U.S.:
A Pew Research Center survey found that 67% of the US supports legalization.(10)
And a Gallup survey found that 66% of Americans are in favor of legalization. That’s up from just 60% in 2016.(11)
On Nov. 4, 2020, New Jersey and Arizona voted to approve amendments to legalize the use of green for those above the age of 21. The next steps for both would be to establish rules for regulation and issue permits for vendors.(12)
Voters in South Dakota approved it for medical use. Even voters in Montana voted to legalize, regulate and tax recreational green for adults 21 and older.
Plus, we have to consider that 11 other states — Washington, Oregon, California, Nevada, Colorado, Michigan, Illinois, Maine, Vermont, Massachusetts, Alaska, and the District of Columbia already allow legal recreational use.
Again, with that kind of growth, Global Market Insights has noted:
“The Cannabidiol (CBD) Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026, with the global market valuation for CB.D crossing $89 billion by 2026.”
Can B Corp. (STOCK:CANB) Packs a Punch in the Industry
CB.D companies like Can B Corp. could thrive in that environment – and fast.
With a market cap of nearly $1.42 million, Can B Corp. is a nano-cap stock. But that’s okay. The core idea with a stock of this size is that at the present time in history, small stocks such as this are seeing the same level of attention normally given to small cap stocks.
Plus, this company is a ground floor stock opportunity, when demand for CB.D products is just beginning to increase. And, many retailers are already finding they can’t keep up with the demand for such products – especially now during the pandemic.
Can B Corp. stock is well worth watching in a space that could be worth $89 billion by 2026.
Health & Wellness company, Can B is provides quality CB.D products under brands:
Pure Leaf Oil,
Pure Health Products,
Green Grow Farms
Can B also used multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct.
However, Can B Corp. (STOCK:CANB) is more than a CB.D company
It’s also a super foods company, a medical device company, and a supplement company.
For example, it’s launching Super Foods, a line of nutritional supplements.
With regards to super foods, the global market is estimated to be worth $244.8 billion with a CAGR of 17% by 2024. In fact, according to Technavio:(13)
“The health benefits of superfoods are boosting their popularity among end-users. Superfruits are rich in fibers, vitamins, antioxidants, polyphenols, and minerals which help in digestion, strengthening the immune system, muscles and bones, and protecting the body from wear and tear. The growing health consciousness and the need for leading a healthier lifestyle are also contributing to the increasing demand for superfoods.”
In addition, Can B Corp.’s (STOCK:CANB) Duramed line combines medical devices with “healing powers” of CB.D. Duramed provides wearable bioelectronic devices for the delivery of sustained acoustic medicine (SAMs).
The SAM Pro 2.0 is the first and only FDA cleared wearable low intensity ultrasound device delivering multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries (muscle, tendon, ligament) and reduce chronic pain (without opioid pain medication).(14)
And it’s collaborating with Dr. Karl Zarse in launching ImmuneX2,a super immune boosting AM/PM supplement – expected to ship by the end of November.
Here’s the Bottom Line on Can B Corp. (STOCK:CANB)
Can B Corp. (STOCK:CANB) offers an exciting ground floor opportunity on a potential $89 billion market opportunity. As demand for CB.D rises with or without the pandemic, some of your best opportunities can be found in micro-cap stocks like this one. Plus, with a small float of 3.07 million shares, better news could help catapult the stock to higher highs.
The Top Reasons Why Can B Corp. (STOCK:CANB) Could See Quite a “Green” Rush
CB.D Is A Safe Even in Uncertain Times: Even with a recent rally, markets are still unpredictable at the moment. However, with BIG demand for CB.D – especially, to combat the stress and anxiety of the pandemic – CB.D is a safe investment opportunity.
Analysts are Bullish on Growth: Analysts at Cowen say sales could reach $16 billion by 2025 with health and wellness products leading the way – and with beverage, food, and beauty playing a big role. And, according to Global Market Insights, “The Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026, with the global market valuation for CB.D crossing $89 billion by 2026.”
Support for legalization is only growing: A Pew Research Center survey found that 67% of the US supports legalization. And a Gallup survey found that 66% of Americans are in favor of legalization. That’s up from just 60% in 2016. In addition, New Jersey and Arizona voted to approve amendments to legalize the use of green for those above the age of 21. The next steps for both would be to establish rules for regulation and issue permits for vendors.
Low Float = Surge on Big News: Can B Corp. has a small market cap of only $1.42 million. Plus, this company is a ground floor stock opportunity, when demand for CB.D products is just beginning to increase. And, many retailers are already finding they can’t keep up with the demand for such products – especially now during the pandemic.
Well diversified: Can B Corp. is also well diversified with super foods (a potential $244.8 million market), medical devices, and supplements.
This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors
We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Pursuant to an agreement between TD Media LLC and Can B Corp., TD Media LLC has been hired for a period beginning on 01/06/21 and ending on 01/19/21 to publicly disseminate information about (CANB) via digital communications. We have been paid fifty thousand USD via bank wire transfer. We own zero shares of (CANB).